Coverage of PET Scans for PET Scan for Thyroid Cancer

For services furnished on or after October 1, 2003, Medicare covers the use of FDG PET for thyroid cancer only for restaging of recurrent or residual thyroid cancers of follicular cell origin that have previously been treated by thyroidectomy and radioiodine ablation and have a serum thyroglobulin > 10ng/ml and negative I-131 whole body scan. Contractors shall advise providers to use the appropriate Procedure code from section 60.3.1 for thyroid cancer for services performed on or after January 28, 2005.

Coverage of PET Scans for Perfusion of the Heart Using Ammonia N-13

Effective for service performed on or after October 1, 2003, PET scans performed at rest or with pharmacological stress used for noninvasive imaging of the perfusion of the heart for the diagnosis and management of patients with known or suspected coronary artery disease using the FDA-approved radiopharmaceutical ammonia N-13 are covered, provided the following requirements are met.